Partnerships & Mergers

The advanced air mobility developer brings its cutting-edge autonomous aerial systems to move critical medical samples between SEHA Sheikh Khalifa Medical City (SKMC) and PureLab’s Abu Dhabi headquarters.

NMC will deploy Opus across its facilities to improve decision-making processes, streamline clinical and administrative workflows, and support better patient outcomes.

The merger has already cleared several regulatory hurdles, having secured approval from the Competition Commission of India (CCI) and received ‘No Objection’ letters from the Stock Exchanges.

BMS will pay up to USD850 million, structured as USD50 million in upfront and near-term payments combined with USD800 million in regulatory, development, and milestone-based payouts.

The newly developed syringe has been specifically engineered to work seamlessly with Ypsomed’s YpsoMate 5.5 autoinjector platform.

This move introduces advanced tools like the da Vinci robotic surgical system, promising to elevate medical care across the region.

Pfizer will assume complete responsibility for developing and bringing to market any vaccine products that utilize Matrix-M technology.

The partnership specifically targets the domestic manufacture of PCV13 using VACSERA’s established production facilities and infrastructure within Egypt.

Orthopaedic surgeons from both Metropolitan Hospital and Marengo Asia Hospitals worked together to perform the procedures.

Built on Microsoft 365 Copilot, Power BI, and Microsoft Azure, the platform enables pharmacists to replace traditional pen-and-paper stock management systems with sophisticated digital tools.